Daniel F Mandri MD

Physician

8785 SW 165th AveSte 200Miami, FL 33193
Phone+1 786-554-0008
Fax+1 786-209-2160

Dr. Mandri is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mandri's full profile Already have an account?

Summary

Dr. Daniel Mandri is a Miami, Florida-based Psychiatrist with an impressive background in medical education and service. He served an internship in Internal Medicine at Christ Medical Center affiliated with the University of Illinois, in Oak Lawn, Illinois This was immediately followed by his Psychiatry Residency at Jackson Memorial Hospital and Veterans Administration Hospital, University of Miami School of Medicine. His dedication and leadership were recognized as he served as chief resident in Psychiatry. His contributions to the field include a notable publication on treating Tardive Dyskinesia (NBI-98854)which has been cited 104 times. His participation in multiple seminars demonstrates a commitment to staying updated on new advancements and practices in psychiatry. He has repeatedly received the American Medical Association Physician Recognition Award since 1989 to present. This award signifies ongoing commitment to continuing medical education and professional development. Dr Mandri has received several accolades, including the Physician's Recognition Award from the American Medical Association and commendations from the Mental Health Association of Dade County and Florida International University. He is affiliated with several professional organizations, including as Fellow of the American Psychiatric Association, member of the Florida Psychiatric Society and the European Psychiatric Association.

dyskinesia, in Movement Disorders, which has been cited 104 times. Dr. Mandri has received several accolades, including the Physician's Recognition Award from the American Medical Association and commendations from the Mental Health Association of Dade County and Florida International University.

Education & Training

University of Miami/Jackson Health SystemResidency, Psychiatry, 1980 - 1983
Advocate Health Care/Advocate Christ Medical CenterInternship, Internal Medicine, 1979 - 1980
Universidad Central del Este Facultad de MedicinaClass of 1977

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 1979 - 2028
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Physician's Recognition Award American Medical Association
Certificate of Commendation Mental Health Association of Dade County
Certificate of Appreciation for Exemplary Service Admission Committee Herbert. Wertheim College of Medicine Florida International University

Publications & Presentations

PubMed

104 citations
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Christopher F. O'Brien, Roland Jimenez, Robert A. Hauser, Stewart A. Factor, Joshua Burke
Movement Disorders. 2015-10-01

Grant Support

Counteracting cardiorespiratory and subjective effects of fentanyl-xylazine mixtures using a dual antagonist approachROWAN UNIVERSITY SCHOOL/OSTEOPATHIC MED2024–2026

Research History

Principal investigatorProtocol xxxxx: A study to assess effectiveness, safety and health related outcomes of xxxxx for the treatment of Pseudobulbar affect in nursing home patients.
Principal InvestigatorProtocol xxxxx: A phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of xxxxx for the treatment of agitation in patients with dementia of the Alzheimer’s type.
Principal investigatorProtocol xxxxx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel, Fixed-Dose Study to Assess the Efficacy, Safety, and Tolerability of xxxxx for the Treatment of Tardive Dyskinesia.